Table 5

Relationships between mutations and MSI patterns
 Mutation status N (%) p
BRAF V600E*
      Positive 18/20 (90%) 1.000
     Negative 17/19 (89%)
RET/PTC*
      Positive 13/16 (81%) 0.642
     Negative 17/19 (89%)
Transitions (IDH1 + NRAS)
      Positive 9/11 (82%) 0.631
     Negative 22/25 (88%)
Point mutations (BRAF + IDH1 + NRAS)
      Positive 35/41 (85%) 1.000
     Negative 22/25 (88%)

* Analysis performed only in the PTC group.

Negative group comprises only samples without any of the alterations investigated.

Santos et al.

Santos et al. BMC Cancer 2013 13:79   doi:10.1186/1471-2407-13-79

Open Data